Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: An in vivo microdialysis study

Neuroscience Letters

Volumn 236, Issue 3, 1997, Pages 151-154

  Zhelyazkova Savova, Maria ^a   Giovannini, Maria Grazia ^b   Pepeu, Giancarlo ^b  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acetylcholine release; Chlorophenylpiperazine; Cortex; Nucleus basalis magnocellularis

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ACETYLCHOLINE; ISOTEOLINE; MESULERGINE; SEROTONIN 1C RECEPTOR; SEROTONIN 2 ANTAGONIST; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN CORTEX; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAGNOCELLULAR NUCLEUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY;

EID: 0030722420     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00785-4     Document Type: Article

References (20)

1. Barnes J.M., Barnes N.M., Costall B., Naylor R.J., Tyers N.B. 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature. 338:1989;762-763.
2. Bolanos F., Fillion G. Minaprine antagonises the serotonergic inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on acetylcholine release. Eur. J. Pharmacol. 168:1989;87-92.
3. Cassel J.C., Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implication. Neuroscience. 69:1995;1-41.
4. Conn P.J., Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J. Pharmacol. Exp. Ther. 242:1987;552-557.
5. Curzon G., Kennett G.A. m-CPP: a tool for studying behavioural responses associated with 5-HT1C receptors. Trends Pharmacol. Sci. 11:1990;181-182.
6. Damsma G., Lammerts Van Bueren D., Westering B.H.C., Horn A.S. Determination of acetylcholine in the femtomole range by means of HPLC, a post-column enzyme reactor, and electrochemical detection. Chromatographia. 24:1987;827-831.
7. Gibson E.L., Barnfield A.M.C., Curzon G. Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetics effects. Neuropharmacology. 33:1994;457-465.
8. Giovannini M.G., Camilli F., Mundula A., Pepeu G. Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem. Int. 25:1994;23-26.
9. Harvey J.A. Serotoninergic regulation of associative learning. Behav. Brain Res. 73:1996;47-50.
10. Hirano H., Day J., Fibiger H.C. Serotoninergic regulation of acetylcholine release in rat frontal cortex. J. Neurochem. 65:1995;1139-1145.
11. Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J. Rec. Res. 8:1988;59-81.
12. Kahn R.S., Wetzler S. m-Chlorophenylpiperazine as a probe of serotonin function. Biol. Psychiat. 30:1991;1139-1166.
13. Lawlor B.A., Sunderland T., Mellow A.M., Hill J.L., Molchan S.E., Murphy D.L. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study. Arch. Gen. Psychiat. 46:1989;542-549.
14. Meneses A., Hong E. Effect of fluoxetine on learning and memory involves multiple 5-HT systems. Pharmacol. Biochem. Behav. 52:1995;341-346.
15. Meneses A., Hong E. A pharmacological analysis of serotoninergic receptors: effects of their activation or blockade in learning. Neuropsychopharmacol. Biol. Psychiat. 21:1997;273-296.
16. Murphy D.L. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology. 3:1990;457-471.
17. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2A and 5-HT2C receptor family mRNA: comparison between 5-HT2A and 5-HT2C receptors. Mol. Brain Res. 23:1994;163-178.
18. Steckler T., Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav. Brain Res. 67:1995;165-199.
19. Zhelyazkov, D., Mollov, N., Markov, M., Philipov, S., Georgiev, N., Zhelyazkova-Savova, M., Petrov, O. and Tarkolev, N., An agent for treatment of hypertonic disease and a method for its synthesis. Invention Authorship Certificate No 43200/13.04.1984 MPK A61 31/485, State Register No. 55261 1982 (in Bulgarian).
20. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-453.